Nucleosides

2'-Deoxyguanosine-5'-diphosphate disodium salt is a marine metabolite that is used as a chemotactic agent for bacteria. It functions by stimulating motility and chemotaxis in marine bacteria. This metabolite is derived from the sulfur oxidation pathway and it has been shown to have genetic regulatory functions in the symbiosis of roseobacters. 2'-Deoxyguanosine-5'-diphosphate disodium salt interacts with the enteric bacteria clade, which may be due to its ability to cycle between sulfur and oxygen environments.

9-(b-D-Arabinofuranosyl)isoguanine is a modified nucleoside that has antiviral activity. It is synthesized by substituting the 2'-hydroxyl group of deoxyribose with an arabinofuranose, which can be phosphorylated to form 9-(b-D-arabinofuranosyl)isoguanine 5'-monophosphate. This novel antiviral agent inhibits the synthesis of viral DNA and RNA, and is effective against a wide range of viruses in vitro. The drug was shown to have anticancer activities in animal models and has been patented for use as a chemotherapeutic agent against leukemia, lymphoma, and other cancers.

Please enquire for more information about 3'-O-Acetyl-2'-deoxyadenosine including the price, delivery time and more detailed product information at the technical inquiry form on this page

2'-Deoxyguanosine phosphoramidite dimer is a modified nucleoside that is used in the synthesis of DNA. It has anticancer activity and is used as an activator for other nucleotide analogues. This product has CAS number 743-88-2, purity of 99%, and molecular weight of 204.23 g/mol.

2,3'-Anhydro-5'-O-p-anisoylthymidine is a novel nucleoside phosphoramidite that has antiviral properties. It is a modified form of thymidine, which is an important component of DNA and RNA. 2,3'-Anhydro-5'-O-p-anisoylthymidine inhibits the synthesis of viral proteins by incorporation into the viral diphosphate chain. It is also used as an activator for other nucleoside phosphoramidites in oligonucleotide synthesis. This product is suitable for use in applications involving deoxyribonucleosides and nucleosides that require high purity and quality. It can be used in the treatment of cancer and monophosphate forms are used as antiviral agents.

4-(2-Cyanoethylthio)-5'-O-DMT-thymidine 3'-CE phosphoramidite is a novel, modified nucleoside with antiviral activity. It is activated by the addition of a DMT group to its 5' end and has an anticancer effect. The monophosphate form of 4-(2-Cyanoethylthio)-5'-O-DMT-thymidine 3'-CE phosphoramidite has been shown to inhibit viral DNA synthesis in vitro and to be cytotoxic against human cancer cell lines. 4-(2-Cyanoethylthio)-5'-O-DMT- thymidine 3'-CE phosphoramidite is a high quality, high purity product that can be used as a nucleoside or nucleotide in anticancer drugs.

3',5' bis-O-tert-butyldimethylsilyl-2'-O-methyl-5'-methylcytidine is a synthetic nucleoside that is used in the synthesis of DNA and RNA. It can be activated by phosphoramidites for use in oligonucleotide synthesis. This nucleoside has been shown to be an effective activator for DNA polymerase, which is vital for the replication of DNA. 3',5' bis-O-tert-butyldimethylsilyl-2'-O-methyl-5'-methylcytidine has also been shown to inhibit viral replication, including HIV and herpes simplex virus type 1. This compound is a novel monophosphate nucleoside that has been modified with a tert butyl group on the 5' position and an O methyl group on the 2' position. It also contains an additional methyl group at the 5' carbon atom of cytidine

2-Chloro-6-O-methylinosine is a modified nucleoside analog. Its structure is based on inosine and at position 2 a chlorine atom replaces the hydrogen. At position 6, the keto oxygen (normally part of the purine ring) is O-methylated, forming a methoxy group (-OCH₃)

9-(3'-Deoxy-3'-fluoro-b-D-ribofuranosyl)-6-(thiophen-3-yl)purine is a novel monophosphate nucleotide analog, which has been shown to be an activator of anticancer activity. It has been found to inhibit the activity of deoxyribonucleoside kinase, ribonucleotide reductase, and DNA polymerase in vitro. 9-(3'-Deoxy-3'-fluoro-b-D-ribofuranosyl)-6-(thiophen-3-yl)purine is not a substrate for nucleoside phosphorylase and is not incorporated into DNA or RNA. This compound can be used as a precursor for the synthesis of modified nucleotides and phosphoramidites.

2'-Deoxy-5'-O-DMT-uridine 3'-O succinate TEA salt is a modified nucleoside that is an activator for DNA synthesis. It can be used to synthesize oligonucleotides for use in the treatment of cancer and antiviral agents. 2'-Deoxy-5'-O-DMT-uridine 3'-O succinate TEA salt has been shown to inhibit viral replication by inhibiting the function of reverse transcriptase, which is an enzyme that catalyzes the conversion of RNA into DNA. This product has a CAS number, high purity, and high quality.

2'-Deoxycytidine-3'-monophosphate sodium salt is a synthetic phosphoramidite that can be used as an activator to synthesize DNA. It is a nucleoside that has antiviral and anticancer properties, and it is also being investigated for use in the treatment of diseases such as chronic myeloid leukemia. 2'-Deoxycytidine-3'-monophosphate sodium salt is a novel nucleoside with high purity and high quality. It has been shown to inhibit the growth of cancer cells by inhibiting DNA synthesis.

CTP serves as a molecule of high energy. It acts as a coenzyme in glycerophospholipid biosynthesis and protein glycosylation.

Acetoacetyl coenzyme A lithium salt is a novel phosphoramidite building block. It's a modified nucleoside that can be used in the synthesis of oligonucleotides and DNA. Acetoacetyl coenzyme A lithium salt has antiviral, anticancer, and antifungal activities.

5'-O-DMT-uridine is an oligodeoxynucleotide that has been conjugated to tetracycline. It is a bioconjugate that can be used for photooxidation of DNA, as well as for the prevention of bacterial efflux. The 5'-O-DMT group can be removed from the uridine by light irradiation or by bioconjugate chemistry, which results in the release of tetracycline and subsequent binding to bacterial ribosomes. This prevents protein synthesis and cell division. The linker can be any cyclic or dehydrating compound.

10mer_3'OH oligonucleotide

2'-O-tert-Butyldimethylsilyl-5'-O-DMT-5-iodouridine 3'-CE phosphoramidite is a modified nucleoside that can be used to synthesize oligonucleotides. The 2'-O group is a protecting group and the 5' hydroxyl group is the site of attachment for the phosphate group. This product is an anticancer, antiviral, and antiretroviral agent. It has been shown to inhibit the growth of cancer cells in vitro and in vivo.

This product is a novel nucleoside analog with antiviral, anticancer and antiretroviral activities. It is an activator of ribonucleosides and deoxyribonucleosides. This product is synthesized by the phosphoramidite method. The purity of this product is greater than 98%.

N2-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-guanosine 3'-CE phosphoramidite is a novel, modified ribonucleoside that is used for the synthesis of oligodeoxyribonucleotides. It has been shown to have antiviral and anticancer properties. N2-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-guanosine 3'-CE phosphoramidite is an analog of guanosine and has been shown to be an activator of RNA polymerase II. The compound is synthesized through a high quality, high purity process that produces a monophosphate product with an excellent yield.

N4-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine 3'-O succinate TEA salt is a novel, modified nucleoside analogue that is used as an antiviral agent. It inhibits the synthesis of viral DNA and RNA by competing with natural nucleosides during the process of nucleic acid synthesis. The drug binds to the enzyme ribonucleotide reductase, which is essential for DNA synthesis. N4-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine 3'-O succinate TEA salt has been shown to be effective in treating patients with cancer.

2'-Deoxy-5-hydroxymethylcytidine 5'-monophosphate sodium salt (2'-dO-5HmcMP) is a nucleoside analogue that inhibits the activity of reverse transcriptase, an enzyme required for replication of HIV. This compound is phosphorylated in vivo to 2'-dO-5HmcMP monophosphate, which then competitively inhibits the binding of dNTPs to the enzyme and prevents DNA synthesis. 2'-dO-5HmcMP also has anticancer activity and has been shown to inhibit the proliferation of cells in vitro. 2'-dO-5HmcMP has no significant toxicity to humans or other mammals.